SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-09-000047
Filing Date
2009-01-16
Accepted
2009-01-16 16:11:31
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 bvfsc13g-a.htm SC 13G/A 257177
  Complete submission text file 0000898432-09-000047.txt   259378
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 200 SOUTH SAN FRANCISCO CA 94025-1918
Business Address 400 OYSTER POINT BOULEVARD SUITE 200 SOUTH SAN FRANCISCO CA 94025-1918 (650) 228-1800
NOVACEA INC (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81821 | Film No.: 09531680
SIC: 2834 Pharmaceutical Preparations